NM Magazine logo

2025, Issue II

Category: Research Briefs

  • Mitochondria May Be a Promising Therapeutic Target for Inflammatory Diseases

    Mitochondria May Be a Promising Therapeutic Target for Inflammatory Diseases

    Scientists in the laboratory of Navdeep Chandel, PhD, the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and Critical Care, have discovered how mitochondria influence the body’s immune response through modulating specific cell signaling pathways, according to a recent study published in Science Advances.

  • Alzheimer’s Treatment May Lie in Brain’s Own Cleanup Crew

    Alzheimer’s Treatment May Lie in Brain’s Own Cleanup Crew

    A new Northwestern Medicine study suggests a promising alternative to current approaches to Alzheimer’s disease: enhancing the brain’s own immune cells to clear amyloid plaques more effectively.

  • Novel Intracellular Mechanisms May Inform Treatments for Congenital Spinal Defects

    Novel Intracellular Mechanisms May Inform Treatments for Congenital Spinal Defects

    Northwestern Medicine investigators have identified novel mechanisms regulating the development of the spinal column during embryonic development, findings that could inform new treatments for congenital scoliosis and other related birth defects, according to a recent study published in Nature Communications.

  • Study Identifies Link Between Body Clock Disruption and Metabolic Disease

    Study Identifies Link Between Body Clock Disruption and Metabolic Disease

    Northwestern Medicine investigators have discovered how disruptions in circadian rhythm in our muscles combined with poor diet can contribute to the development of diabetes, according to a recent study published in Proceedings of the National Academy of Sciences.

  • Reprogramming Compromised Immune Cells to Fight Cancer

    Reprogramming Compromised Immune Cells to Fight Cancer

    Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, according to a study published in Science Advances.

  • Novel Mechanisms Regulate Immune Response to Cancer and Infection

    Novel Mechanisms Regulate Immune Response to Cancer and Infection

    Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and respond to disease and acute inflammation, findings that may inform the development of targeted therapies for cancer and tissue injury, according to a recent study published in the Journal of Clinical Investigation.

  • The Antibiotic that Takes the Bite Out of Lime

    The Antibiotic that Takes the Bite Out of Lime

    In two new studies led by bacteriologist Brandon L. Jutras, Northwestern scientists have identified an antibiotic that cures Lyme disease at a fraction of the dosage of the current “gold standard” treatment and discovered what may cause a treated infection to mimic chronic illness in patients.

  • Scientists Discover a Cause of Lupus and a Possible Way to Reverse It

    Scientists Discover a Cause of Lupus and a Possible Way to Reverse It

    Northwestern Medicine and Brigham and Women’s Hospital scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and in a study published in Nature, show that reversing this defect may potentially reverse the disease.

  • Study Identifies Racial Differences in Rare Endometrial Cancer

    Study Identifies Racial Differences in Rare Endometrial Cancer

    Northwestern Medicine investigators have discovered that uterine serous carcinoma tumors in Black patients express more aggressive and immunosuppressive features than tumors in white patients, according to a recent study published in the Proceedings of the National Academy of Sciences.

  • Non-Neuron Brain Cells Produce a Third of Amyloid Plaque in Alzheimer’s Disease

    Non-Neuron Brain Cells Produce a Third of Amyloid Plaque in Alzheimer’s Disease

    An international team of investigators have discovered that non-neuron brain cells called oligodendrocytes contribute to approximately one-third of plaque formation alongside that produced by neurons in mouse models of Alzheimer’s disease, according to a recent study published in Nature Neuroscience.